Since the Obama administration launched its accountable care initiative as part of healthcare reform in 2012, the CMS has announced which hospital and physician networks in one of the programs have met cost targets and received shared savings. But so far, it has published little data on quality of care delivered by these networks, which were designed to deliver better care as well as lower costs for Medicare patients.
Since the Obama administration launched its accountable care initiative as part of healthcare reform in 2012, the CMS has announced which hospital and physician networks in one of the programs have met cost targets and received shared savings. But so far, it has published little data on quality of care delivered by these networks, which were designed to deliver better care as well as lower costs for Medicare patients.
The $380 million in Medicare savings produced by accountable care organizations in the Shared Savings and Pioneer programs in 2012 have been well-publicized. But the CMS has not yet delivered on its stated goal of transparency for quality-of-care measures, which will be used to evaluate Medicare ACOs to determine whether they will receive financial bonuses or penalties. Quality measures ensure that ACOs—which are eligible to keep half to 70% of what they save—do not inappropriately skimp on care to win the savings bonuses.
“If you're going to collect 33 (quality) measures, I don't know why it is that the public doesn't have access to that information,” said Dr. Robert Berenson, an expert on Medicare policy and senior fellow at the Urban Institute. Public access to the data adds “credibility and accountability” to the ACO program and could help Medicare beneficiaries decide whether to join an ACO if proposals to establish enrollment in the program are enacted, Berenson said. Lack of confidence in the validity of the quality data may be one reason for delays, he said.
Read the full story here: http://bit.ly/1oq3BCg
Source: Modern Healthcare
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen